Vera Therapeutics, Inc.
VERA
$37.25
$4.2512.88%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 27.46M | 21.95M | 15.92M | 15.57M | 9.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 83.93M | 80.14M | 57.19M | 48.91M | 49.80M |
| Operating Income | -83.93M | -80.14M | -57.19M | -48.91M | -49.80M |
| Income Before Tax | -80.29M | -76.53M | -51.69M | -43.42M | -46.63M |
| Income Tax Expenses | -- | -- | -- | 1.00K | -- |
| Earnings from Continuing Operations | -80.29M | -76.53M | -51.69M | -43.43M | -46.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -80.29M | -76.53M | -51.69M | -43.43M | -46.63M |
| EBIT | -83.93M | -80.14M | -57.19M | -48.91M | -49.80M |
| EBITDA | -83.80M | -80.02M | -57.11M | -48.86M | -49.78M |
| EPS Basic | -1.26 | -1.20 | -0.81 | -0.72 | -0.85 |
| Normalized Basic EPS | -0.79 | -0.75 | -0.51 | -0.45 | -0.53 |
| EPS Diluted | -1.26 | -1.20 | -0.81 | -0.72 | -0.85 |
| Normalized Diluted EPS | -0.79 | -0.75 | -0.51 | -0.45 | -0.53 |
| Average Basic Shares Outstanding | 63.85M | 63.79M | 63.67M | 60.69M | 54.90M |
| Average Diluted Shares Outstanding | 63.85M | 63.79M | 63.67M | 60.69M | 54.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |